TSMHT
AGIO icon

Thurston Springer Miller Herd & Titak’s Agios Pharmaceuticals AGIO Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.94K Hold
241
– – ﹤0.01% 866
2026
Q1 		$8.15K Hold
241
– – ﹤0.01% 946
2025
Q4 		$6.56K Buy
+241
New +$8.46K ﹤0.01% 1054

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Thurston Springer Miller Herd & Titak's AGIO Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 241 shares worth $8.94K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Thurston Springer Miller Herd & Titak first reported a position in AGIO in Q4 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 241 shares of Agios Pharmaceuticals worth $8.94K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #866 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.